<DOC>
	<DOCNO>NCT02414230</DOCNO>
	<brief_summary>The purpose research study evaluate tau distribution brain subject : ALS cause different genetic mutation , mutation carrier ( without symptom ) , non-mutation carrier , sporadic FTD , normal control .</brief_summary>
	<brief_title>F 18 T807 Tau PET Imaging Familial Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>1 . Male female participant , least 18 year age . 2 . Clinically diagnosed amyotrophic lateral sclerosis ( ALS ) , frontotemporal dementia ( FTD ) , ; carrier mutation know cause ALS FTD ( without symptom ) ; normal control . 3 . Participant able willing undergo testing ( psychometric testing , MRI CT , PET , radioactive tracer injection ; unable undergo MRI , CT use generate regionsofinterest ) . 4 . Premenopausal woman undergo urine pregnancy test within 24 hour drug administration . 1 . Has condition , Investigator 's opinion , could increase risk participant , limit participant 's ability tolerate experimental procedure , interfere collection/analysis data ( example , participant significant respiratory involvement may able lie flat scanning procedure ) . 2 . Is deem likely unable perform imaging procedure reason . 3 . Has high risk Torsades de Pointes take medication know prolong QT interval . 4 . Has hypersensitivity F 18 T807 excipients . 5 . Contraindications PET , PETCT MR ( e.g . electronic medical device , inability lie still long period ) make unsafe individual participate . 6 . Severe claustrophobia . 7 . Currently pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>fronto-temporal dementia</keyword>
	<keyword>Tauopathies</keyword>
	<keyword>Nervous System Diseases</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
</DOC>